Audit 93428

FY End
2022-06-30
Total Expended
$147.48M
Findings
2
Programs
43
Organization: Temple University Health System (PA)
Year: 2022 Accepted: 2023-03-24

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
98124 2022-001 - - L
674566 2022-001 - - L

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $113.28M Yes 0
93.855 Allergy and Infectious Diseases Research $5.35M - 0
93.393 Cancer Cause and Prevention Research $2.55M - 0
93.396 Cancer Biology Research $2.45M - 0
93.859 Biomedical Research and Research Training $2.40M - 0
93.395 Cancer Treatment Research $1.84M - 0
12.420 Military Medical Research and Development $1.54M - 0
93.461 Hrsa Covid-19 Uninsured Program $1.53M Yes 0
93.397 Cancer Centers Support Grants $1.39M - 0
93.307 Minority Health and Health Disparities Research $1.27M - 0
93.398 Cancer Research Manpower $653,543 - 0
93.310 Trans-Nih Research Support $646,866 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $532,033 - 0
93.397 National Institute of Health $422,723 - 0
93.839 Blood Diseases & Resources Research $418,455 - 0
93.855 National Institute of Health $350,574 - 0
93.847 Diabetes, Digestive & Kidney Diseases Research $325,442 - 0
93.865 Child Health and Human Development $288,134 - 0
93.575 Child Care and Development Block Grant $263,923 - 0
93.853 National Institute of Health $251,555 - 0
93.RD Nci Prevent Preclinical Drug Development Program $241,353 - 0
93.853 Extramural Research Programs in Neurosciences $192,556 - 0
93.788 State Targeted Response to the Opioid Crisis Grants $124,763 - 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $110,782 Yes 1
93.435 Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke $90,043 - 0
93.113 Environmental Health $88,520 - 0
93.394 National Institute of Health $74,972 - 0
93.353 National Institute of Health $63,933 - 0
12.420 Thomas Jefferson University $48,839 - 0
12.420 Stanford University $48,691 - 0
93.394 Cancer Detection and Diagnosis Research $46,282 - 0
93.395 National Institute of Health $39,950 - 0
93.396 National Institute of Health $36,905 - 0
93.866 National Institute of Health $33,932 - 0
93.393 National Institute of Health $32,131 - 0
93.837 National Institute of Health $25,382 - 0
93.RD Nci Sherlock Lung $24,900 - 0
93.399 National Institute of Health $20,115 - 0
47.079 Office of International Science & Engineering $19,561 - 0
12.420 Vanderbilt University $17,041 - 0
93.RD Centers for Disease Control and Prevention $15,485 - 0
93.839 National Institute of Health $2,355 - 0
93.172 National Institute of Health $318 - 0

Contacts

Name Title Type
LJACYN6HKY48 Angela Freestone Auditee
2157076149 John Neary Auditor
No contacts on file

Notes to SEFA

Title: STATE OF PENNSYLVANIA FUNDED PROGRAMS Accounting Policies: 1.BASIS OF PRESENTATIONThe accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of certain subsidiaries of Temple University Health System, Inc. (the Health System) (a wholly owned subsidiary of Temple Universityof The Commonwealth System of Higher Education) under programs of the federal government for the year ended June 30, 2022. The Schedule includes the expenditures of Institute for Cancer Research, doing business as the Research Institute of Fox Chase Cancer Center (a wholly owned subsidiary of American Oncologic Hospital), Temple Center for Population Health, LLC, which is a wholly owned subsidiary of Temple University Health System, Inc., Temple University Hospital, Inc., Temple Faculty Practice Plan, Inc., Temple Physicians, Inc., Fox Chase Cancer Center Medical Group, Inc., and American Oncologic Hospital, doing business as The Hospital of Fox Chase Cancer Center.Because the Schedule presents only a selected portion of the operations of the Health System, it is not intended to, and does not, present the financial position, revenues, expenses, and changes in net assets of the Health System.For the purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the Health System and agencies or departments of the federal government and all subawards to the Health System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements.BASIS OF ACCOUNTING: SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS The Schedule is presented using the accrual basis of accounting. The amounts reported in the schedule as expenditures may differ from certain financial reports submitted to federal, state or city funding agencies due to those reports being submitted on either a cash or modified accrual basis of accounting.CONSOLIDATED FINANCIAL STATEMENTS The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP) and include the accounts of the Health System. All significant intercompany transactions and balances have been eliminated in consolidation. De Minimis Rate Used: N Rate Explanation: The Health System has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The Health System received state financial assistance from the Commonwealth of Pennsylvania. The Commonwealth of Pennsylvania financial assistance is not reflected in the Schedule of Expenditures of Federal Awards. These Commonwealth of Pennsylvania financial assistance awards are not audited.
Title: SUBSEQUENT EVENTS Accounting Policies: 1.BASIS OF PRESENTATIONThe accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of certain subsidiaries of Temple University Health System, Inc. (the Health System) (a wholly owned subsidiary of Temple Universityof The Commonwealth System of Higher Education) under programs of the federal government for the year ended June 30, 2022. The Schedule includes the expenditures of Institute for Cancer Research, doing business as the Research Institute of Fox Chase Cancer Center (a wholly owned subsidiary of American Oncologic Hospital), Temple Center for Population Health, LLC, which is a wholly owned subsidiary of Temple University Health System, Inc., Temple University Hospital, Inc., Temple Faculty Practice Plan, Inc., Temple Physicians, Inc., Fox Chase Cancer Center Medical Group, Inc., and American Oncologic Hospital, doing business as The Hospital of Fox Chase Cancer Center.Because the Schedule presents only a selected portion of the operations of the Health System, it is not intended to, and does not, present the financial position, revenues, expenses, and changes in net assets of the Health System.For the purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the Health System and agencies or departments of the federal government and all subawards to the Health System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements.BASIS OF ACCOUNTING: SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS The Schedule is presented using the accrual basis of accounting. The amounts reported in the schedule as expenditures may differ from certain financial reports submitted to federal, state or city funding agencies due to those reports being submitted on either a cash or modified accrual basis of accounting.CONSOLIDATED FINANCIAL STATEMENTS The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP) and include the accounts of the Health System. All significant intercompany transactions and balances have been eliminated in consolidation. De Minimis Rate Used: N Rate Explanation: The Health System has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The Health System has evaluated subsequent events through March 24, 2023 and has determined that there are no subsequent events requiring adjustment to or disclosure in the consolidated financial statements.
Title: 5.PENNSYLVANIA DEPARTMENT OF HEALTH Accounting Policies: 1.BASIS OF PRESENTATIONThe accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of certain subsidiaries of Temple University Health System, Inc. (the Health System) (a wholly owned subsidiary of Temple Universityof The Commonwealth System of Higher Education) under programs of the federal government for the year ended June 30, 2022. The Schedule includes the expenditures of Institute for Cancer Research, doing business as the Research Institute of Fox Chase Cancer Center (a wholly owned subsidiary of American Oncologic Hospital), Temple Center for Population Health, LLC, which is a wholly owned subsidiary of Temple University Health System, Inc., Temple University Hospital, Inc., Temple Faculty Practice Plan, Inc., Temple Physicians, Inc., Fox Chase Cancer Center Medical Group, Inc., and American Oncologic Hospital, doing business as The Hospital of Fox Chase Cancer Center.Because the Schedule presents only a selected portion of the operations of the Health System, it is not intended to, and does not, present the financial position, revenues, expenses, and changes in net assets of the Health System.For the purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the Health System and agencies or departments of the federal government and all subawards to the Health System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements.BASIS OF ACCOUNTING: SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS The Schedule is presented using the accrual basis of accounting. The amounts reported in the schedule as expenditures may differ from certain financial reports submitted to federal, state or city funding agencies due to those reports being submitted on either a cash or modified accrual basis of accounting.CONSOLIDATED FINANCIAL STATEMENTS The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP) and include the accounts of the Health System. All significant intercompany transactions and balances have been eliminated in consolidation. De Minimis Rate Used: N Rate Explanation: The Health System has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance As required by the Pennsylvania Department of Health, the following additional information pertains to each federal program passed through the Pennsylvania Department of Health: (See Notes to Schedule of Expenditures of Federal Awards for the Table)
Title: 6.PROVIDER RELIEF FUND Accounting Policies: 1.BASIS OF PRESENTATIONThe accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of certain subsidiaries of Temple University Health System, Inc. (the Health System) (a wholly owned subsidiary of Temple Universityof The Commonwealth System of Higher Education) under programs of the federal government for the year ended June 30, 2022. The Schedule includes the expenditures of Institute for Cancer Research, doing business as the Research Institute of Fox Chase Cancer Center (a wholly owned subsidiary of American Oncologic Hospital), Temple Center for Population Health, LLC, which is a wholly owned subsidiary of Temple University Health System, Inc., Temple University Hospital, Inc., Temple Faculty Practice Plan, Inc., Temple Physicians, Inc., Fox Chase Cancer Center Medical Group, Inc., and American Oncologic Hospital, doing business as The Hospital of Fox Chase Cancer Center.Because the Schedule presents only a selected portion of the operations of the Health System, it is not intended to, and does not, present the financial position, revenues, expenses, and changes in net assets of the Health System.For the purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the Health System and agencies or departments of the federal government and all subawards to the Health System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements.BASIS OF ACCOUNTING: SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS The Schedule is presented using the accrual basis of accounting. The amounts reported in the schedule as expenditures may differ from certain financial reports submitted to federal, state or city funding agencies due to those reports being submitted on either a cash or modified accrual basis of accounting.CONSOLIDATED FINANCIAL STATEMENTS The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP) and include the accounts of the Health System. All significant intercompany transactions and balances have been eliminated in consolidation. De Minimis Rate Used: N Rate Explanation: The Health System has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance The following providers received funding from ALN 93.498 Provider Relief Fund: (See Notes to Schedule of Expenditures of Federal Awards for the Table)

Finding Details

TEMPLE UNIVERSITY HEALTH SYSTEM SCHEDULE OF FINDINGS AND QUESTIONED COSTS FOR FEDERAL AWARDS FOR THE YEAR ENDED JUNE 30, 2022 Reference Number: 2022-001 Prior Year Finding: No Federal Agency: U.S. Department of the Treasury Pass-through Agency: Pennsylvania Commission on Crime and Delinquency Federal Program: Coronavirus State and Local Fiscal Recovery Funds/Comprehensive Response to Violence ALN Number: 21.027 Compliance Requirement: Reporting Type of Finding: Deficiency, Noncompliance Criteria or specific requirement: The Comprehensive Response to Violence (CRV) Program Reports are due within twenty (20) days after each quarterly reporting period. Condition: Temple University Health System (TUHS) received funding from the U.S Department of the Treasury, passed-through from the Pennsylvania Commission on Crime and Delinquency (PCCD) for the CRV Program. TUHS was required to submit quarterly CRV Program Reports to the PCCD. All Program Reports were submitted. However, we noted that two (2) reports were submitted after the due dates prescribed by PCCD. Cause: TUHS did not ensure that reports were submitted by the required due dates. Effect: The funding agency could reject the report and terminate the reimbursement request. Questioned costs: None. Recommendation: We recommend that the Health System submit the required reports time frame prescribed by the pass-through entity. Views of responsible officials and planned corrective actions: Management acknowledges the finding and notes that two (2) of the CRV Program Reports were not submitted timely. Going forward, the program?s manager will submit the reports according to the time frame prescribed. Also, see ?Corrective Action Plan?
TEMPLE UNIVERSITY HEALTH SYSTEM SCHEDULE OF FINDINGS AND QUESTIONED COSTS FOR FEDERAL AWARDS FOR THE YEAR ENDED JUNE 30, 2022 Reference Number: 2022-001 Prior Year Finding: No Federal Agency: U.S. Department of the Treasury Pass-through Agency: Pennsylvania Commission on Crime and Delinquency Federal Program: Coronavirus State and Local Fiscal Recovery Funds/Comprehensive Response to Violence ALN Number: 21.027 Compliance Requirement: Reporting Type of Finding: Deficiency, Noncompliance Criteria or specific requirement: The Comprehensive Response to Violence (CRV) Program Reports are due within twenty (20) days after each quarterly reporting period. Condition: Temple University Health System (TUHS) received funding from the U.S Department of the Treasury, passed-through from the Pennsylvania Commission on Crime and Delinquency (PCCD) for the CRV Program. TUHS was required to submit quarterly CRV Program Reports to the PCCD. All Program Reports were submitted. However, we noted that two (2) reports were submitted after the due dates prescribed by PCCD. Cause: TUHS did not ensure that reports were submitted by the required due dates. Effect: The funding agency could reject the report and terminate the reimbursement request. Questioned costs: None. Recommendation: We recommend that the Health System submit the required reports time frame prescribed by the pass-through entity. Views of responsible officials and planned corrective actions: Management acknowledges the finding and notes that two (2) of the CRV Program Reports were not submitted timely. Going forward, the program?s manager will submit the reports according to the time frame prescribed. Also, see ?Corrective Action Plan?